Precipio (Precipio) Institutional Ownership : 6.30% (As of May. 24, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Precipio Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Precipio's institutional ownership is 6.30%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Precipio's Insider Ownership is 31.45%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Precipio's Float Percentage Of Total Shares Outstanding is 92.45%.

Precipio Institutional Ownership Historical Data

The historical data trend for Precipio's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precipio Institutional Ownership Chart

Precipio Historical Data

The historical data trend for Precipio can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	9.90	8.59	7.81	4.72	4.44	6.99	7.00	6.61	6.70	6.30

Precipio Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Precipio (Precipio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (NAS:PRPO) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Science Park, New Haven, CT, USA, 06511

Website

https://www.precipiodx.com

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.

Executives

Richard A Sandberg	director	330 NEVEDA STREET, NEWTON MA 02460-1458
Ahmed Zaki Sabet	officer: Chief Operations Officer	33 ANDYS DR, EAST HAVEN CT 06512
Ilan Danieli	director, officer: Chief Executive Officer	14707 CALIFORNIA STREET, SUITE 5, OMAHA NE 68154
Matthew Gage	officer: Chief Financial Officer	56 STAGECOACH CIRCLE, MILFORD CT 06460
David Seth Cohen	director, 10 percent owner	C/O STANDARD OIL, 299 BISHOP AVENUE, BRIDGEPORT CT 06610
Ronald Asbury Andrews	director	5791 VAN ALLEN WAY, CARLSBAD CA 92008
Randal J Kirk	10 percent owner	1881 GROVE AVENUE, RADFORD VA 24141
Kathleen Laporte	director
Robert Patzig	director	THE GOVERNOR TYLER, 1881 GROVE AVENUE, RADFORD VA 24141
Michael A Luther	director	21 CORPORATE CIRCLE, ALBANY NY 12203
Jeffrey Cossman	director	C/O PRECIPIO INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Samuel D Riccitelli	director	2850 FRONTIER DR., WARSAW IN 46582
Carl Iberger	officer: Chief Financial Officer	C/O PRECIPIO, INC., 12325 EMMET STREET, OMAHA NE 68164
Douglas Fisher	director	587 PATROL RD, WOODSIDE CA 94062
Mark Rimer	director, 10 percent owner	C/O PRECIPIO, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511